Funder: American Society for Pharmacology and Experimental Therapeutics
Due Dates (Anticipated): September 2028 (Nomination deadline)
Funding Amounts: $50,000 per year for two years ($100,000 total)
Summary: Supports preclinical or clinical pharmacology research addressing funding gaps or generating preliminary data to improve human health.
Key Information: Applicants must be current ASPET members in good standing and at least 45 by the nomination deadline.
Description
The David Lehr Research Award is administered by the American Society for Pharmacology and Experimental Therapeutics (ASPET) through its Scientific Achievement Awards program. It extends funding for preclinical or clinical research directed toward improving human health, particularly work that may introduce novel pharmacologic approaches or technologies. Applicants must demonstrate a clear need for funding to maintain research productivity.
The award encourages investigators seeking bridging funds for a competitive renewal, additional support during a no-cost extension to strengthen a resubmission, or preliminary data for a new grant submission. It is supported by an endowment from Mrs. Lisa Lehr honoring Dr. David Lehr, former chair of Pharmacology at New York Medical College, and is presented biennially in odd-numbered years at the ASPET Annual Meeting.
